# Collaborative research on influenza and other respiratory pathogens in South Africa

Source: https://welltoldgrants.com/grants/rfa-ip-24-017-collaborative-research-on-influenza-and-other-respiratory/  
Official notice: https://www.grants.gov/search-results-detail/351637

> Centers for Disease Control and Prevention - ERA offered grants of up to $2.5 million (at least $1.0 million) to the applicants described in the notice. It expected to make one award worth $15.0 million in total. Applications closed on March 7, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-IP-24-017 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | March 7, 2024 |
| Award ceiling | $2.5 million |
| Award floor | $1.0 million |
| Expected awards | 1 |
| Total funding | $15.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.083, 93.326 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

National Institute for Communicable Diseases, Republic of South Africa

## What the grant funds

The purpose of this notice of funding opportunity is to conduct research studies on influenza and other respiratory pathogens of public health import in South Africa. The National Center for Immunization and Respiratory Diseases (NCIRD) in CDC is seeking to initiate a cooperative agreement with the National Institute for Communicable Diseases (NICD), Republic of South Africa, to conduct research on surveillance (inclusive of the epidemiology, disease burden, transmission, and laboratory methods), preventive tools and strategies (e.g., vaccines, antivirals), and strategies for increasing coverage of morbidity and mortality mitigating interventions. Data will be used to inform prioritization of public health interventions in high-risk populations in South Africa, the region, and globally.

## Questions people ask

### Is RFA-IP-24-017 still open?

No. It closed on March 7, 2024. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Collaborative research on influenza and other respiratory pathogens in South Africa?

Centers for Disease Control and Prevention - ERA accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Collaborative research on influenza and other respiratory pathogens in South Africa?

Closed March 7, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $2.5 million each. About $15.0 million in total for one award.

### Who has won Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases grants before?

The largest recipients over five fiscal years were Council of Medical Specia, Post-Acute and Long-Term Care Medical Association, Inc., National Health Laboratory Service. The program made 30 awards worth $58.2 million in that time.